NS4b inhibitors (GlaxoSmithKline)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNS4b inhibitors (GlaxoSmithKline)
Drug Alias NameGSK-853A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNonstructural protein 4B inhibitors
TargetsNonstructural protein 4B
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenelabs Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcGenelabs Technologies Inc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A